Aarhus, Denmark, 20 June 2023 – NMD Pharma A/S, a clinical stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular disorders, presented the results from ...

In the evolving landscape of pain management and rehabilitation, neuromuscular retraining has emerged as a paradigm-shifting approach that addresses the underlying causes of musculoskeletal pain ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...

Neuromuscular blockade is an essential component of modern anaesthetic practice, enabling muscle relaxation during surgery and facilitating procedures such as tracheal intubation and minimally ...

Founded in 2017by CEO Hooman Lee (trained in Convergence at Seoul National University; former researcher at ETRI), EXOSYSTEMS is venture-backed (Kakao Ventures, SBI Investment, Laguna Investment, ...

Simultaneously achieving ultra-softness, ultrahigh sensitivity and mechanical resiliency is a major challenge for wearable electronics and soft machines. The soft yet wearable sensors with their ...

Core stability and muscle balance has been a popular topic in health, fitness and athletic training for the past decade. The attraction can be purely for esthetics or it may be driven by injury or ...

January 2026 Time: 8:00-8:25am PST Room: Golden Gate Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA NMD Pharma has recently completed enrollment of a Phase 2a clinical trial in ...

Magnesium, an essential mineral, serves as a cofactor in numerous enzymatic reactions critical for optimal physiological function. It plays a pivotal role in muscle function, nerve transmission, and ...